These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20725134)

  • 41. Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.
    Dhaun N; Strachan FE; Newby DE; Johnston NR; Ford NF; Hammett JL; Palmisano M; Webb DJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):611-22. PubMed ID: 16305585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH; Warner TD
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis.
    Larose E; Behrendt D; Kinlay S; Selwyn AP; Ganz P; Fang JC
    Circ Heart Fail; 2009 Sep; 2(5):409-16. PubMed ID: 19808370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
    Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P
    Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits.
    Dumont AS; Lovren F; McNeill JH; Sutherland GR; Triggle CR; Anderson TJ; Verma S
    J Neurosurg; 2001 Feb; 94(2):281-6. PubMed ID: 11213966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles.
    Donato AJ; Lesniewski LA; Delp MD
    Cardiovasc Res; 2005 May; 66(2):393-401. PubMed ID: 15820208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous endothelin generation maintains vascular tone in humans.
    Webb DJ
    J Hum Hypertens; 1995 Jun; 9(6):459-63. PubMed ID: 7473528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
    Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
    Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of endothelin-1 and BQ 123 on arterioles and venules of hypertensive rats.
    Hergenröder S; Münter K; Kirchengast M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S226-9. PubMed ID: 8587371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin-A-mediated vasoconstriction during exercise with advancing age.
    Barrett-O'Keefe Z; Ives SJ; Trinity JD; Morgan G; Rossman MJ; Donato AJ; Runnels S; Morgan DE; Gmelch BS; Bledsoe AD; Richardson RS; Wray DW
    J Gerontol A Biol Sci Med Sci; 2015 May; 70(5):554-65. PubMed ID: 24821105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ENDOTHELIN-1 SYTEM ACTIVITY IN ADULTS WITH BORDERLINE HIGH LDL-CHOLESTEROL.
    Diehl KJ; Stauffer BL; Greiner JJ; DeSouza CA
    Artery Res; 2014 Sep; 8(3):115-118. PubMed ID: 25267931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-reported habitual short sleep duration is associated with endothelial fibrinolytic dysfunction in men: a preliminary report.
    Weil BR; Greiner JJ; Stauffer BL; Desouza CA
    Sleep; 2013 Feb; 36(2):183-8. PubMed ID: 23372265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature.
    Hijmans JG; Levy M; Garcia V; Lincenberg GM; Diehl KJ; Greiner JJ; Stauffer BL; DeSouza CA
    Exp Physiol; 2019 Jun; 104(6):975-982. PubMed ID: 31016755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones.
    Schinzari F; Tesauro M; Cardillo C
    Physiol Res; 2018 Jun; 67(Suppl 1):S69-S81. PubMed ID: 29947529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association Between Habitual Night Sleep Duration and Predicted 10-Year Cardiovascular Risk by Sex Among Young and Middle-Aged Adults.
    He J; Wang Y; Zhang L; Li C; Qi X; Wang J; Guo P; Chen S; Niu Y; Liu F; Zhang R; Li Q; Ma S; Zhang M; Hong C; Zhang M
    Nat Sci Sleep; 2022; 14():911-926. PubMed ID: 35586455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Individual differences in habitual short sleep duration and dysfunction: Subjective health versus objective cardiovascular disease risk.
    Williams PG; Barger SD; Curtis BJ
    Health Psychol; 2021 Sep; 40(9):587-596. PubMed ID: 34843320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin-1 and psychosocial risk factors for cardiovascular disease: a systematic review.
    Yammine L; Kang DH; Baun MM; Meininger JC
    Psychosom Med; 2014 Feb; 76(2):109-21. PubMed ID: 24434952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.